Reunion Neuroscience Inc
Change company Symbol lookup
Select an option...
REUN Reunion Neuroscience Inc
MMND Mastermind Inc
FRC First Republic Bank
BXP Boston Properties Inc
ABB Abb Ltd
FNKO Funko Inc
WDH Waterdrop Inc
DGX Quest Diagnostics Inc
PEAR Pear Therapeutics Inc
ALT Altimmune Inc
Go

Health Care : Biotechnology | Small Cap Blend
Based in Canada
Company profile

Reunion Neuroscience Inc. is engaged in the psychedelic drug development company that provides therapeutic solutions for mental health conditions by developing serotonin receptor agonist compounds. The Company is developing the advancement of synthetic molecules targeting serotonin 5HT2A receptors. The Company’s products include RE104 and RE200. The Company’s lead asset, RE-104, which is a psychedelic drug being developed for post-partum and treatment resistant depression as a potential fast-acting antidepressant with durable efficacy. The RE104 as a potentially fast-acting treatment for the key indications of postpartum and treatment resistant depression. The Company is developing the RE200 series, which includes compounds with potential for more selective serotonin receptor activity with reduced psych activity for potential use in more chronic treatment paradigms and indications. The Company is focused on the research and development of its RE200 molecule group.

The symbol you entered, FTRPF, changed to REUN.

Closing Price
$0.8301
Day's Change
-0.0274 (-3.20%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.8883
Day's Low
0.83
Volume
(Light)
Volume:
23,449

10-day average volume:
37,569
23,449
  • Prev Close
    0.8575
  • Today's Open
    0.87
  • Day's Range
    0.83-0.8883
  • Avg Vol (10-day)
    37.6K
  • Last (time)
    3:54p ET 03/21/23
  • Last (size)
    10
  • 52-Wk Range
    0.7603 - 8.70
    LowHigh
  • (03/21/22 - 03/20/23)
    9.18%
  • 91.5%
  • Market Cap
    9.7M
  • Shares Outstanding
    11.6M
  • -3.94
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 3.2
  • 12.99
  • (% of float 02/28/23)
    0.64

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.